Alcon issued a global recall of CyPass Micro-Stent and advised surgeons to immediately stop implanting the device in patients after reviewing long-term safety data, Verdict Medical Devices reports. 1.
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Glaukos said new approvals for its micro-scale surgical implants were its first under the EU’s new and more stringent Medical Device Regulation pathway, or MDR. (Getty Images) Glaukos has claimed a ...
Minimally invasive techniques in glaucoma management encompass a spectrum of microincisional procedures designed to lower intraocular pressure (IOP) with fewer complications than traditional ...
Glaucoma, an eye disease that can cause irreversible blindness, is a major health concern worldwide. It is caused by a build-up of fluid in the eye, which leads to increased pressure inside the eye.
The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma. The stent, produced by Fort Worth, Texas-based Alcon, is a micro-invasive surgical device used ...
John A. Moran Eye Center alumnus Iqbal "Ike" Ahmed, MD, FRCSC, will tell you he is not afraid of controversy. "Challenge the norm. Challenge what we do…but do it respectfully," Ahmed advised residents ...
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...
Moran Global Outreach Division Medical Director and glaucoma surgeon Craig J. Chaya, MD, is leading an initiative to train doctors and healthcare workers in Tanzania to provide critically needed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results